Buys
Open market- Shares
- Avg price
- Total value
Daniel Janney - Director at Krystal Biotech, Inc.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- KRYS on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Daniel Janney in Krystal Biotech, Inc.
Sells
Open market- Shares
- -71,964
- Avg price
- $269.61
- Total value
- -$19,402,207
Net
Past year- Shares
- -71,964
- Share %
- -100%
- Total value
- -$19,402,207
Reported holdings for Daniel Janney in Krystal Biotech, Inc.
Form 4 holding
Director
Krystal Biotech, Inc.
- Security class
- Common Stock
- Shares / value
- 73,293
- Estimated value
- $20,241,071
- Report date
- 27 Feb 2026
- Price
- $276.17
- Ownership
- Directly beneficially owned by Alta Bioequities, L.P.
Form 4 holding
Director
Krystal Biotech, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 0
- Estimated value
- Report date
- 24 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Daniel Janney in Krystal Biotech, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.